We hypothesized that the double targeting of G9a/DNMT1 in human and murine NSCLC models would have a strong impact on tumor growth in combination with other therapies, as a result of CM-272-mediated gene expression reprogramming leading to chemosensitization. This evidence concerns the gene DNMT1 and non-small cell lung carcinoma.